Session Details

S004 Hot Topics

Fri, Mar 8, 9:00 AM - 12:00 AM
Room 20B
3 CME Available Symposium Practice Management
View Map

DESCRIPTION

The symposium will address those 'hot topics' established by registrant consensus, a true reflection of member concerns and interests. The session will be a 'potpourri' of medical/surgical topics, including some with social and economic import. Expert speakers will provide 'state of the art' material, highlighting recent trends and developments and accenting emerging and innovative therapies. Presentations will be derm relevant, clinically germane, and directly applicable to patient care.

LEARNING OBJECTIVES

1.

Diagnose skin diseases more effectively.

2.

Recognize the medical/surgical implications of those entities, including diagnosis and treatment, especially emerging and innovative therapies.

3.

Apply evolving evidence-based knowledge to patient care.

SCHEDULE

9:00 AM

Welcome/Introduction

Kenneth J. Tomecki, MD, FAAD

9:05 AM

Acne: What's New

Andrea L. Zaenglein, MD, FAAD

9:30 AM

Hairy Matters: What's New in Alopecia

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

9:55 AM

Cosmeceuticals: Naturally Absurd

Cheri Frey, MD, FAAD

10:20 AM

Atopic Dermatitis: New Developments

Emma Guttman, MD, PhD, FAAD

10:45 AM

Biologics and Psoriasis: the Beat Goes On

Joseph Merola, MD, MSc, FAAD

11:10 AM

Melanoma Update

Allan C. Halpern, MD, FAAD

11:35 AM

What’s New in Derm Surgery

Anthony V. Benedetto, DO, FAAD

DIRECTOR

Kenneth J. Tomecki, MD, FAAD

Kenneth J. Tomecki, MD, FAAD

SPEAKERS

Anthony V. Benedetto, DO, FAAD

Anthony V. Benedetto, DO, FAAD

Cheri Frey, MD, FAAD

Cheri Frey, MD, FAAD

Emma Guttman, MD, PhD, FAAD

Emma Guttman, MD, PhD, FAAD

Allan C. Halpern, MD, FAAD

Allan C. Halpern, MD, FAAD

Joseph Merola, MD, MSc, FAAD

Joseph Merola, MD, MSc, FAAD

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

Andrea L. Zaenglein, MD, FAAD

Andrea L. Zaenglein, MD, FAAD

HANDOUTS

Login to view handouts

DISCLOSURES

Anthony V. Benedetto, DO, FAAD

AbbVie – Investigator(Fees), Stockholder Private Company(Fees); BioDelivery Systems, Inc. – Stockholder(Stock Options); Bristol-Myers Squibb – Stockholder(Stock); Castle Biosciences, Inc – Advisory Board(Honoraria); GSK PLC – Stockholder Private Company(Stock); Ipsen – Speaker(Honoraria); IQVIA – Investigator(Fees); Merz Pharmaceuticals, LLC – Stockholder Public Company(No Compensation Received); Organogenesis, Inc. – Speaker/Faculty Education(Honoraria), Speaker/Faculty Education(Stock); Stratapharma – Consultant(Honoraria), Investigator(Honoraria), Speaker(Honoraria);

Cheri Frey, MD, FAAD

AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Acclaro Medical – Speaker/Faculty Education(Honoraria); Aerolase – Speaker/Faculty Education(Honoraria); Avene – Speaker(Honoraria); Beiersdorf – Consultant (1099 relationship)(Honoraria); Benev – Advisory Board(Honoraria); Bubble Skincare – Consultant (1099 relationship)(Honoraria); CeraVe – Investigator(Grants/Research Funding); CeraVe/Valeante – Advisory Board(Honoraria); Crown Laboratories, Inc. – Advisory Board(Honoraria); Estee Lauder – Independent Contractor(Honoraria); Galderma USA – Speaker(Fees); Incyte Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Johnson and Johnson – Advisory Board(Honoraria); Kenvue – Advisory Board(Honoraria); La Mer – Consultant (1099 relationship)(Honoraria); La Roche Posay Dermatologique – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Advisory Board(Honoraria); Primus Pharmaceuticals – Advisory Board(Honoraria); Procter & Gamble Company – Speaker/Faculty Education(Honoraria); Regeneron – Advisory Board(Honoraria); Restore Biologics – Stockholder Private Company(Stock); Sanofi – Consultant (1099 relationship)(Fees); SkinBetter Science – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); VeraDermics Inc. – Independent Contractor(Honoraria);

Emma Guttman, MD, PhD, FAAD

AbbVie – Consultant(Fees), Consultant(Honoraria); Almirall – Consultant(Fees); Amgen – Consultant(Fees), Investigator(Grants/Research Funding); AnaptysBio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apollo Therapeutics Ltd – Investigator(Grants/Research Funding); Artax Biopharma – Consultant (1099 relationship)(Fees); Astria Therapeutics – Consultant (1099 relationship)(Fees); Bambusa Therapeutics Inc – Consultant (1099 relationship)(Fees); Biolojic Design – Consultant (1099 relationship)(Fees); Bionyra Pharma – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Celldex – Consultant (1099 relationship)(Fees); Cue Biopharma – Consultant (1099 relationship)(Fees); CytoReason – Consultant (1099 relationship)(Fees); DBV Technologies – Consultant (1099 relationship)(Fees); Dualitas Therapeutics – Consultant (1099 relationship)(Fees); Electra Therapeutics – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); EMD Serono – Consultant (1099 relationship)(Fees); Enveda Biosciences – Consultant (1099 relationship)(Fees); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma Research & Development, LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Generate Biomedicines – Consultant (1099 relationship)(Fees); Gilead Sciences, Inc – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Infimmune – Consultant (1099 relationship)(Fees); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen – Consultant (1099 relationship)(Fees); Jasper Therapeutics – Consultant (1099 relationship)(Fees); Kymera Therapeutics – Consultant (1099 relationship)(Fees); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Matchpoint Therapeutics – Consultant (1099 relationship)(Fees); Merck – Consultant(Fees), Consultant(Honoraria); Navigator Medicines – Consultant (1099 relationship)(Fees); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Opsidio – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Propeller Bio – Consultant (1099 relationship)(Fees); Proteologix US Inc – Consultant (1099 relationship)(Fees); RAPT Therapeutics – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria), Consultant (1099 relationship)(Stock Options), Investigator(Grants/Research Funding); RayThera – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Rubedo Life Sciences – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); SATO Pharmaceutical Co., Ltd – Consultant(Fees); Sitryx – Consultant (1099 relationship)(Fees); Sun Pharma Advanced Research Company (SPARC) – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); Teva – Consultant (1099 relationship)(Fees); TRex Bio – Consultant (1099 relationship)(Fees); Triveni Bio – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Ventyx Biosciences – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Consultant (1099 relationship)(Fees); VRG Therapeutics – Consultant (1099 relationship)(Fees); Xencor – Consultant (1099 relationship)(Fees);

Allan C. Halpern, MD, FAAD

Canfield Scientific, Inc. – Consultant(Other Financial Benefit); SpotDoc – Founder(Other Financial Benefit);

Joseph Merola, MD, MSc, FAAD

Consultant(Honoraria); Amgen – Advisory Board(Honoraria); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Honoraria); Galderma – Consultant (1099 relationship)(Fees); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Novartis – Consultant(Honoraria); Pfizer Inc. – Investigator(Fees); Sanofi/Regeneron – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB – Consultant(Honoraria);

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);

Kenneth J. Tomecki, MD, FAAD

No financial relationships exist with ineligible companies.

Andrea L. Zaenglein, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Biofrontera AG – Investigator(Grants/Research Funding); Church & Dwight Co., Inc. – Consultant(Fees); Dermavant Sciences, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);